With numerous bibliographies on special subjects.

Includes information on electronically published databases with details of content, size, access and pricing as well as commentary on the major databases.

Greene’s history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care.

Issues for 1977-1979 include also Special List journals being indexed in cooperation with other institutions. Citations from these journals appear in other MEDLARS bibliographies and in MEDLING, but not in Index medicus.

Aggregator products in FSO include: - DataStar- Dialog- EBSCO host- Eureka- Europresse- Factiva- FirstSearch- GBI- Genios- Infomart- InfoTrac- InSite- LexisNexis- NewsBank- Newscan- NewsLibrary- Nikkei Net Interactive- Ovid- Pressed (EDD)- Profound- ProQuest- Questel- Quicklaw- RBB- STN- International- Westlaw- Wilson Web FSO subscribers also receive access to the Private Zone, a hyperlinked list of publications with free archives available on the Internet. The Private Zone provides access to fulltext back issues of individual publications found in the print edition of FSO.

Drugs are considered to be healers and harmers, wonder substances and knowledge makers; objects that impact on social hierarchies, health practices and public policies. This book focuses on the ways that gender, race/ethnicity and class, influence the design, standardisation and circulation of drugs throughout several highly medicalised countries. Seventeen authors from eight different countries, both European and non-European, analyse the extent to which the dominant ideas and values surrounding masculinity and femininity shape the research, prescription and use of drugs by women and/or men within particular social and cultural contexts.